Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06059443 · ClinicalTrials.gov registry record · NA

mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention

A NA study of HIV Infections and Syphilis, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06059443 is a NA study of HIV Infections and Syphilis that has completed, run by Columbia University. The registered enrollment target is 40 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06059443, a NA study of HIV Infections and Syphilis, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

Men who have sex with men (MSM), especially young men who have sex with men (YMSM), and transgender women (TGW) have some of the highest rates of HIV and syphilis diagnoses in the United States. The goal of this study is to pilot the mobile Lab (mLab) App Plus to assess YMSM's and YTGW's abilities to perform and interpret self-tests for HIV and syphilis and consequently increase the number of YMSM and young transgender woman (YTGW) who initiate self-testing for HIV and syphilis.

Conditions Studied

HIV Infections Syphilis Sexually Transmitted Diseases, Viral

Interventions

  • BEHAVIORAL mLab App Plus

Study Locations (2)

New York

  • Columbia University Irving Medical Center - New York

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-10-17
Est. Completion 2024-06-21
Phase NA

Sponsor

Columbia University

958 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06059443

The ClinicalTrials.gov registry entry for NCT06059443 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (91% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which mLab App Plus is the first listed.

NCT06059443 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New York, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06059443 about?

NCT06059443 is a clinical study titled "mLab App Plus: A Randomized Controlled Trial of a Mobile Health (mHealth) Intervention". Men who have sex with men (MSM), especially young men who have sex with men (YMSM), and transgender women (TGW) have some of the highest rates of HIV and syphilis diagnoses in the United States. The goal of this study is to pilot the mobile Lab (mLab) App Plus to assess YMSM's and YTGW's abilities t...

What is the current status of trial NCT06059443?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2023-10-17. Estimated completion is 2024-06-21.

What conditions does trial NCT06059443 study?

This clinical trial studies the following conditions: HIV Infections, Syphilis, Sexually Transmitted Diseases, Viral.

What interventions are being tested in trial NCT06059443?

The interventions under investigation include: mLab App Plus (BEHAVIORAL).

Who is sponsoring clinical trial NCT06059443?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06059443 being conducted?

This trial has 2 study locations across New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Syphilis

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.